Stocks and Investing Stocks and Investing
Tue, December 19, 2023
Mon, December 18, 2023

Jay Olson Maintained (BIIB) at Buy with Increased Target to $295 on, Dec 18th, 2023


Published on 2024-10-28 08:03:10 - WOPRAI, Jay Olson
  Print publication without navigation


Jay Olson of Oppenheimer, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $280 to $295 on, Dec 18th, 2023.

Jay has made no other calls on BIIB in the last 4 months.



There are 9 other peers that have a rating on BIIB. Out of the 9 peers that are also analyzing BIIB, 1 agrees with Jay's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $239 on, Thursday, November 9th, 2023


These are the ratings of the 8 analyists that currently disagree with Jay


  • Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $287 on, Thursday, December 14th, 2023
  • Danielle Brill of "Raymond James" Upgraded from Hold to Buy and Held Target at $283 on, Thursday, December 7th, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $373 on, Friday, November 10th, 2023
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $365 on, Thursday, November 9th, 2023
  • Evan Seigerman of "BMO Capital" Maintained at Buy with Decreased Target to $295 on, Thursday, November 9th, 2023
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $363 on, Thursday, November 9th, 2023
  • Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $305 on, Thursday, October 26th, 2023
  • Morten Herholdt of "HSBC" Initiated at Strong Buy and Held Target at $360 on, Wednesday, September 6th, 2023
Contributing Sources